Xi Hongfei, Liu Jiasi, Xu Tao, Li Zhe, Mou Xuanting, Jin Yu, Xia Shudong
Department of Cardiology, the Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu, China.
Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Front Cardiovasc Med. 2023 Mar 10;10:1117915. doi: 10.3389/fcvm.2023.1117915. eCollection 2023.
To analyze the risk factors of in-stent restenosis (ISR) after the first implantation of drug-eluting stent (DES) patients with coronary heart disease (CHD) and to establish a nomogram model to predict the risk of ISR.
This study retrospectively analyzed the clinical data of patients with CHD who underwent DES treatment for the first time at the Fourth Affiliated Hospital of Zhejiang University School of Medicine from January 2016 to June 2020. Patients were divided into an ISR group and a non-ISR (N-ISR) group according to the results of coronary angiography. The least absolute shrinkage and selection operator (LASSO) regression analysis was performed on the clinical variables to screen out the characteristic variables. Then we constructed the nomogram prediction model using conditional multivariate logistic regression analysis combined with the clinical variables selected in the LASSO regression analysis. Finally, the decision curve analysis, clinical impact curve, area under the receiver operating characteristic curve, and calibration curve were used to evaluate the nomogram prediction model's clinical applicability, validity, discrimination, and consistency. And we double-validate the prediction model using ten-fold cross-validation and bootstrap validation.
In this study, hypertension, HbA1c, mean stent diameter, total stent length, thyroxine, and fibrinogen were all predictive factors for ISR. We successfully constructed a nomogram prediction model using these variables to quantify the risk of ISR. The AUC value of the nomogram prediction model was 0.806 (95%CI: 0.739-0.873), indicating that the model had a good discriminative ability for ISR. The high quality of the calibration curve of the model demonstrated the strong consistency of the model. Moreover, the DCA and CIC curve showed the model's high clinical applicability and effectiveness.
Hypertension, HbA1c, mean stent diameter, total stent length, thyroxine, and fibrinogen are important predictors for ISR. The nomogram prediction model can better identify the high-risk population of ISR and provide practical decision-making information for the follow-up intervention in the high-risk population.
分析首次植入药物洗脱支架(DES)的冠心病(CHD)患者支架内再狭窄(ISR)的危险因素,并建立列线图模型预测ISR风险。
本研究回顾性分析了2016年1月至2020年6月在浙江大学医学院附属第四医院首次接受DES治疗的CHD患者的临床资料。根据冠状动脉造影结果将患者分为ISR组和非ISR(N-ISR)组。对临床变量进行最小绝对收缩和选择算子(LASSO)回归分析以筛选出特征变量。然后,我们结合LASSO回归分析中选择的临床变量,使用条件多变量逻辑回归分析构建列线图预测模型。最后,采用决策曲线分析、临床影响曲线、受试者操作特征曲线下面积和校准曲线来评估列线图预测模型的临床适用性、有效性、区分度和一致性。并且我们使用十折交叉验证和自助法验证对预测模型进行双重验证。
在本研究中,高血压、糖化血红蛋白、平均支架直径、总支架长度、甲状腺素和纤维蛋白原均为ISR的预测因素。我们使用这些变量成功构建了一个列线图预测模型,以量化ISR风险。列线图预测模型AUC值为0.806(95%CI:0.739-0.873),表明该模型对ISR具有良好的区分能力。模型校准曲线的高质量证明了模型的强一致性。此外,DCA和CIC曲线显示了模型的高临床适用性和有效性。
高血压、糖化血红蛋白、平均支架直径、总支架长度、甲状腺素和纤维蛋白原是ISR的重要预测因素。列线图预测模型可以更好地识别ISR的高危人群,并为高危人群的后续干预提供实用的决策信息。